{
    "2021-04-05": [
        [
            {
                "time": "",
                "original_text": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
                "features": {
                    "keywords": [
                        "医药行业",
                        "调整",
                        "均衡",
                        "内生成长",
                        "一二线公司"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一文看懂为何近期医疗服务、医美标的股价反弹涨幅较大",
                "features": {
                    "keywords": [
                        "医疗服务",
                        "医美",
                        "股价反弹",
                        "涨幅较大"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗服务",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}